spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

ASPIRE: International EDGE Conference

Edge Clinical - Aspire International Edge Conference

28 February - 1 March 2018
The Vox Conference Centre, Birmingham

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.

Delegates will gain access to a mix of breakout sessions and workshop sessions as well as hear from various inspirational keynote speakers from across the research field.

The ASPIRE conference is being hosted at a bigger and better conference facility where delegates have further opportunities available to develop their skills and truly be inspired to aim higher and achieve more within their research role.

Gain access to 350 researchers A range of sponsorship and exhibitor opportunities are also available which will allow you to promote your organisation and/or engage and network with all delegates over the 2 days.

If you are interested in finding out more about sponsorship and exhibitor opportunities or you would like to attend the ASPIRE conference then please feel free to contact us on edgecomms@soton.ac.uk.
phone +44 (0)23 82027 200
email edgecomms@soton.ac.uk
web www.edgeclinical.com/edge-conference-2018
email the Vox Conference Centre, Birmingham
 
Print this page
Send to a friend
   
spacer
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>


News and Press Releases

Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

• Collaboration to accelerate development and manufacturing of Bispecific Antibody • Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement